Sydler Remedies Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 5.00 Cr
as on 23-10-2024
- Company Age 21 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 47.45 Cr
as on 23-10-2024
- Satisfied Charges ₹ 66.88 Cr
as on 23-10-2024
- Revenue -12.70%
(FY 2023)
- Profit -47.01%
(FY 2023)
- Ebitda 18.71%
(FY 2023)
- Net Worth 6.48%
(FY 2023)
- Total Assets -2.55%
(FY 2023)
About Sydler Remedies
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 5.00 Cr.
The company currently has active open charges totaling ₹47.45 Cr. The company has closed loans amounting to ₹66.88 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rohit Yambal, Pankaj Yambal, and Nishikant Jain serve as directors at the Company.
- CIN/LLPIN
U24230MH2003PTC141791
- Company No.
141791
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Aug 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Sydler Remedies Private Limited offer?
Sydler Remedies Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Cosmetics, Hair & Beauty Products, Herbal Body Care Cosmetics, Nutraceuticals & Dietary Supplements, Nutritional Supplements, Cereals & Food Grains, Food Grains, Common Disease Medicines, Cough Syrup.
Who are the key members and board of directors at Sydler Remedies?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Pankaj Yambal | Director | 04-Mar-2008 | Current |
Rohit Yambal | Director | 04-Mar-2008 | Current |
Nishikant Jain | Director | 04-Mar-2008 | Current |
Financial Performance and Corporate Structure Insights of Sydler Remedies.
Sydler Remedies Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 12.7% decrease. The company also saw a substantial fall in profitability, with a 47.01% decrease in profit. The company's net worth moved up by a moderate rise of 6.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Sydler Remedies?
In 2023, Sydler Remedies had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Sydler Technologies Private LimitedActive 11 years 1 month
Rohit Yambal and Pankaj Yambal are mutual person
- Stantech Pharmaceuticals Private LimitedActive 19 years 6 months
Rohit Yambal and Pankaj Yambal are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Hdfc Bank Limited Creation Date: 10 Jan 2024 | ₹2.37 M | Open |
Hdfc Bank Limited Creation Date: 02 Nov 2022 | ₹1.24 Cr | Open |
Sidbi Creation Date: 26 Jul 2022 | ₹2.64 Cr | Open |
How Many Employees Work at Sydler Remedies?
Sydler Remedies has a workforce of 117 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sydler Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sydler Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.